An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia
Open Access
- 16 June 1998
- journal article
- Published by Wiley in FEBS Letters
- Vol. 429 (3), 365-369
- https://doi.org/10.1016/s0014-5793(98)00632-2
Abstract
We have recently demonstrated that myocardial adaptation to ischemia triggers a tyrosine kinase regulated signaling pathway leading to the translocation and activation of p38 MAP kinase and MAPKAP kinase 2. Since oxidative stress is developed during ischemic adaptation and since free radicals have recently been shown to function as an intracellular signaling agent leading to the activation of nuclear transcription factor, NFκB, we examined whether NFκB was involved in the ischemic adaptation process. Isolated perfused rat hearts were adapted to ischemic stress by repeated ischemia and reperfusion. Hearts were pretreated with genistein to block tyrosine kinase while SB 203580 was used to inhibit p38 MAP kinases. Ischemic adaptation was associated with the nuclear translocation and activation of NFκB which was significantly blocked by both genistein and SB 203580. The ischemically adapted hearts were more resistant to ischemic reperfusion injury as evidenced by better function recovery and less tissue injury during post‐ischemic reperfusion. Ischemic adaptation developed oxidative stress which was reflected by increased malonaldehyde formation. A synthetic peptide containing a cell membrane‐permeable motif and nuclear sequence, SN 50, which blocked nuclear translocation of NFκB during ischemic adaptation, significantly inhibited the beneficial effects of adaptation on functional recovery and tissue injury. In concert, SN 50 reduced the oxidative stress developed in the adapted myocardium. These results demonstrate that p38 MAP kinase might be upstream of NFκB which plays a role in ischemic preconditioning of heart.Keywords
This publication has 27 references indexed in Scilit:
- High Expression and Activation of MAP Kinase-activated Protein Kinase 2 in Cardiac Muscle CellsJournal of Molecular and Cellular Cardiology, 1997
- Genistein, a Tyrosine Kinase Inhibitor, Blocks the “Second Window of Protection” 48 h after Ischemic Preconditioning in the RabbitJournal of Molecular and Cellular Cardiology, 1997
- Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat heartsFEBS Letters, 1996
- Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehydeJournal of Molecular and Cellular Cardiology, 1995
- Transient Overexpression of Catalase Does Not Inhibit TNF- or PMA-Induced NF-κB ActivationBiochemical and Biophysical Research Communications, 1995
- Gene expression on acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stressJournal of Molecular and Cellular Cardiology, 1995
- Effects of Preconditioning on Reperfusion Arrhythmias, Myocardial Functions, Formation of Free Radicals, and Ion Shifts in Isolated Ischemic/Reperfused Rat HeartsJournal of Cardiovascular Pharmacology, 1994
- Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism.Circulation Research, 1993
- Comparisons of ESR and HPLC methods for the detection of OH. radicals in ischemic/reperfused heartsBiochemical Pharmacology, 1993
- Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsalCell, 1990